ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
The Cost Effectiveness of BG-12 (Dimethyl Fumarate) for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada
Value in Health
◽
10.1016/j.jval.2013.08.1826
◽
2013
◽
Vol 16
(7)
◽
pp. A623
◽
Cited By ~ 2
Author(s):
W. Su
◽
A. Walker
◽
S. Sarda
◽
A.R. Kansal
◽
C. Vicente
◽
...
Keyword(s):
Multiple Sclerosis
◽
Cost Effectiveness
◽
Dimethyl Fumarate
◽
Relapsing Remitting
◽
Remitting Multiple Sclerosis
◽
The Cost
◽
Relapsing Remitting Multiple Sclerosis
Download Full-text
Related Documents
Cited By
References
The cost-effectiveness of delayed-release dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis in Canada
Journal of Medical Economics
◽
10.3111/13696998.2016.1164174
◽
2016
◽
Vol 19
(7)
◽
pp. 718-727
◽
Cited By ~ 12
Author(s):
Wenqing Su
◽
Anuraag Kansal
◽
Colin Vicente
◽
Baris Deniz
◽
Sujata Sarda
Keyword(s):
Multiple Sclerosis
◽
Cost Effectiveness
◽
Dimethyl Fumarate
◽
Delayed Release
◽
Relapsing Remitting
◽
Remitting Multiple Sclerosis
◽
The Cost
◽
Relapsing Remitting Multiple Sclerosis
Download Full-text
The Cost-Effectiveness Of Delayed-Release Dimethyl Fumarate Versus Glatiramer Acetate For The Treatment Of Relapsing-Remitting Multiple Sclerosis In The Chilean National Health Fund (Fonasa)
Value in Health
◽
10.1016/j.jval.2016.09.491
◽
2016
◽
Vol 19
(7)
◽
pp. A431
Author(s):
C Noda
◽
JA de Anda
◽
P Anaya
◽
P Serafini
◽
M Machado
Keyword(s):
Multiple Sclerosis
◽
Cost Effectiveness
◽
Glatiramer Acetate
◽
National Health
◽
Dimethyl Fumarate
◽
Health Fund
◽
Relapsing Remitting
◽
Remitting Multiple Sclerosis
◽
The Cost
◽
Relapsing Remitting Multiple Sclerosis
Download Full-text
The Cost-Effectiveness Of Delayed Release Dimethyl Fumarate Versus Glatiramer Acetate For The Treatment Of Relapsing-Remitting Multiple Sclerosis In The Mexican Social Security Institute (Imss)
Value in Health
◽
10.1016/j.jval.2016.09.494
◽
2016
◽
Vol 19
(7)
◽
pp. A432
Author(s):
JA de Anda
◽
C Noda
◽
P Anaya
◽
A Azamar
◽
M Machado
◽
...
Keyword(s):
Multiple Sclerosis
◽
Cost Effectiveness
◽
Social Security
◽
Glatiramer Acetate
◽
Dimethyl Fumarate
◽
Relapsing Remitting
◽
Remitting Multiple Sclerosis
◽
The Cost
◽
Relapsing Remitting Multiple Sclerosis
◽
Social Security Institute
Download Full-text
The cost-effectiveness of disease-modifying therapies for the treatment of relapsing-remitting multiple sclerosis
Journal of Medical Economics
◽
10.1080/13696998.2016.1258366
◽
2016
◽
Vol 20
(3)
◽
pp. 297-302
◽
Cited By ~ 12
Author(s):
Duygu Bozkaya
◽
Terrie Livingston
◽
Kristen Migliaccio-Walle
◽
Tanner Odom
Keyword(s):
Multiple Sclerosis
◽
Cost Effectiveness
◽
Disease Modifying Therapies
◽
Relapsing Remitting
◽
Disease Modifying
◽
Remitting Multiple Sclerosis
◽
The Cost
◽
Relapsing Remitting Multiple Sclerosis
Download Full-text
The Impact of Neutralizing Antibody Testing on The Cost-Effectiveness of Injectable Disease Modifying Treatments for Relapsing Remitting Multiple Sclerosis
Value in Health
◽
10.1016/j.jval.2015.03.1657
◽
2015
◽
Vol 18
(3)
◽
pp. A284
Author(s):
M Andreykiv
◽
A Plich
◽
A Prüfert
◽
L Heemstra
◽
A Van Engen
Keyword(s):
Multiple Sclerosis
◽
Cost Effectiveness
◽
Neutralizing Antibody
◽
Antibody Testing
◽
Relapsing Remitting
◽
Disease Modifying
◽
Remitting Multiple Sclerosis
◽
The Cost
◽
Relapsing Remitting Multiple Sclerosis
◽
The Impact
Download Full-text
PNL8 ASSESSING THE COST-EFFECTIVENESS OF IMMUNOMODULATORYTHERAPIES FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS BASED ON LONG-TERM DATA
Value in Health
◽
10.1016/s1098-3015(10)64557-3
◽
2006
◽
Vol 9
(3)
◽
pp. A81-A82
Author(s):
CF Bell
◽
JB Graham
◽
SR Earnshaw
◽
M Oleen-Burkey
◽
J Castelli-Haley
◽
...
Keyword(s):
Multiple Sclerosis
◽
Cost Effectiveness
◽
Relapsing Remitting
◽
Remitting Multiple Sclerosis
◽
The Cost
◽
Relapsing Remitting Multiple Sclerosis
◽
Term Data
Download Full-text
Cost-Effectiveness of Dimethyl Fumarate Treatment for Relapsing-Remitting Multiple Sclerosis From A Danish Perspective
Value in Health
◽
10.1016/j.jval.2015.09.2469
◽
2015
◽
Vol 18
(7)
◽
pp. A758
◽
Cited By ~ 2
Author(s):
J Olsen
◽
A Wiren
Keyword(s):
Multiple Sclerosis
◽
Cost Effectiveness
◽
Dimethyl Fumarate
◽
Relapsing Remitting
◽
Remitting Multiple Sclerosis
◽
Relapsing Remitting Multiple Sclerosis
Download Full-text
The Cost-Effectiveness of Disease Modifying Therapies for The Treatment of Relapsing-Remitting Multiple Sclerosis
Value in Health
◽
10.1016/j.jval.2015.03.1653
◽
2015
◽
Vol 18
(3)
◽
pp. A283
◽
Cited By ~ 2
Author(s):
D. Bozkaya
◽
T.P. Livingston
◽
K. Migliaccio-Walle
◽
S. Mehta
◽
T. Odom
Keyword(s):
Multiple Sclerosis
◽
Cost Effectiveness
◽
Disease Modifying Therapies
◽
Relapsing Remitting
◽
Disease Modifying
◽
Remitting Multiple Sclerosis
◽
The Cost
◽
Relapsing Remitting Multiple Sclerosis
Download Full-text
Cost-Effectiveness Of Delayed-Release Dimethyl Fumarate Compared To Glatiramer Acetate And Fingolimod For The Treatment Of Relapsing-Remitting Multiple Sclerosis
Value in Health
◽
10.1016/j.jval.2014.03.356
◽
2014
◽
Vol 17
(3)
◽
pp. A60-A61
◽
Cited By ~ 2
Author(s):
J.A. Mauskopf
◽
M. Fay
◽
R. Iyer
◽
T. Livingston
Keyword(s):
Multiple Sclerosis
◽
Cost Effectiveness
◽
Glatiramer Acetate
◽
Dimethyl Fumarate
◽
Delayed Release
◽
Relapsing Remitting
◽
Remitting Multiple Sclerosis
◽
Relapsing Remitting Multiple Sclerosis
Download Full-text
Cost-Effectiveness Analysis of Delayed-Release Dimethyl-Fumarate In The Treatment of Relapsing-Remitting Multiple Sclerosis In Italy
Value in Health
◽
10.1016/j.jval.2015.09.2598
◽
2015
◽
Vol 18
(7)
◽
pp. A697
◽
Cited By ~ 4
Author(s):
G Furneri
◽
L Santoni
◽
C Marchesi
◽
S Iannazzo
◽
P Cortesi
◽
...
Keyword(s):
Multiple Sclerosis
◽
Cost Effectiveness
◽
Dimethyl Fumarate
◽
Cost Effectiveness Analysis
◽
Delayed Release
◽
Effectiveness Analysis
◽
Relapsing Remitting
◽
Remitting Multiple Sclerosis
◽
Relapsing Remitting Multiple Sclerosis
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close